Perry Nisen - CEO @ Quanta Therapeutics - Crunchbase Person Profile

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

202,395

Primary Job Title CEO
Primary Organization
Quanta Therapeutics

Location San Francisco, California, United States
Regions San Francisco Bay Area, West Coast, Western US
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Perry Nisen is based out of San Francisco, California and is the Chief Executive Officer at Quanta Therapeutics. Perry previously worked at Sanford Burnham as a Chief Executive Officer. Perry attended the Albert Einstein College of Medicine.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	XyloCor Therapeutics	Sofinnova Investments	—	Series A - XyloCor Therapeutics	obfuscated obfuscation
obfuscated obfuscation	XyloCor Therapeutics	Sofinnova Investments	Yes	Series A - XyloCor Therapeutics	obfuscated obfuscation

Jobs

Number of Current Jobs

Perry Nisen

is the

CEO

Quanta Therapeutics

Quanta Therapeutics CEOJun 2021

Board and Advisor Roles

Number of Current Board & Advisor Roles

Perry Nisen

is the

Board Member

XyloCor Therapeutics

XyloCor Therapeutics Board Member

Related Hubs

Hub Name	CB Rank (Hub)
West Coast Therapeutics Companies	18,805
Biotechnology Late Stage Companies With Less Than $50M in Revenue	39,965
Health Care Late Stage Companies With Fewer Than 50 Employees	55,111
Western US Therapeutics Companies	14,987
West Coast Late Stage Companies With Less Than $10M in Revenue	48,187
Surveyor Capital Portfolio Companies	77,279
San Francisco Bay Area Startups Founded in 2018	46,500
San Francisco Health Care Companies	32,949
West Coast Medical Device Companies	18,743
San Francisco Bay Area Late Stage Companies With Less Than $10M in Revenue	99,909

Education

Perry Nisen

studied at

Albert Einstein College of Medicine

Albert Einstein College of Medicine MD/PhD

Recent News and Activity

There is no recent news or activity for this profile.